Intracranial astrocytomas are rarely diagnosed in cats. Clinical and pathological aspects of these tumors are more often described in humans and dogs. The classification scheme used in human medicine is of important prognostic value. We have analyzed clinical neurological and pathological findings from 8 cats with intracranial astrocytomas. The animals were 10.1 years old in average and presented with a history of tetraparesis (n = 3), epilepsy (n = 2), loss of balance (n = 3) and dyspnoe (n = 1). The latter cat died immediately after the first presentation while the other animals were euthanized because of a progressive course of the symptoms despite therapy. Even though feline astrocytomas, that we could classify into 4 different types in this study, are clinically and pathologically well correlated with those of other species, a prognostically useful classification has never been established before.
A six-year-old female Birman cat was referred to our clinic because of chronic progressive changes in behavior. Additionally, generalized vestibular ataxia and psychomotor seizures were noticed. A multifocal lesion in the forebrain as well as brainstem was suspected. Ancillary investigations such as complete blood cell count, serum biochemistry profile, urinalysis and cerebrospinal fluid examination revealed no significant abnormalities. Electroencephalography showed diffuse changes in the cortical activity. Feline spongiform encephalopathy was confirmed by histological brain examination and positive immunohistochemistry for PrPSc. This is the first time that a case of feline spongiform encephalopathy is diagnosed in Switzerland.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.